Description
| Product Name | CAT.No | Size |
| PSA | BXL0852A | 96T |
Product Description
The Biorex Diagnostics Prostate Specific Antigen (PSA) CLIA Kit is a quantitative chemiluminescent immunoassay (CLIA) designed for the accurate measurement of total PSA in human serum. PSA is a serine protease produced mainly by the prostate gland and serves as a critical biomarker for evaluating prostate health. Its measurement is widely used for the early detection of prostate abnormalities, assessment of benign prostatic hyperplasia (BPH), prostatitis, and for monitoring patients with prostate cancer. Accurate quantification supports timely clinical decisions, guides treatment planning, and helps assess therapeutic efficacy.
This kit provides high sensitivity and specificity, allowing laboratories to reliably detect clinically significant levels of the antigen. The microplate format enables the simultaneous analysis of multiple samples, which improves workflow efficiency in busy clinical and research settings. Each kit is supplied with ready-to-use reagents, calibrators, and controls, reducing preparation errors and ensuring consistent, reproducible results across different runs and laboratory environments.
Key Features
- Quantitative CLIA Microplate Assay – delivers precise measurement of total antigen concentrations.
- High Sensitivity and Specificity – enables accurate assessment of physiologically and clinically relevant levels.
- Reliable Reproducibility – ensures consistent performance across multiple assays and laboratory settings.
- Ready-to-Use Kit – includes all necessary reagents, standards, and controls for streamlined workflow.
- Versatile Clinical and Research Applications – suitable for screening, diagnosis, treatment monitoring, and investigative studies.
Routine use of this assay supports early detection of prostate disorders and monitoring of therapeutic interventions. Its reliable performance enhances laboratory efficiency and provides clinicians with actionable information for patient care. The robust design of the kit ensures reproducibility and accuracy, making it ideal for hospitals, diagnostic laboratories, and research institutions. By integrating this quantitative assay into standard protocols, healthcare providers can maintain high standards in prostate health assessment, enable timely interventions, and optimize patient outcomes while supporting ongoing clinical research.
Contact Us for more information.